How EMA's PRIME Scheme Is Shaping Regulatory Affairs Work for Priority Medicines
EMA's PRIME scheme compresses development timelines and turns scientific advice into an ongoing relationship. What that means for regulatory affairs teams.
One morning email with every new regulatory, quality & compliance role your alert matches.
Showing 13–24 of 201 articles
EMA's PRIME scheme compresses development timelines and turns scientific advice into an ongoing relationship. What that means for regulatory affairs teams.
Software validation, human factors, and new agency frameworks for algorithm-driven systems are turning surgical robotics into a distinct regulatory hiring niche.
The pharmacovigilance liaison connects drug safety and regulatory affairs, turning safety findings into timely regulatory action. What the role actually involves.
The MHRA's Innovative Licensing and Access Pathway is pulling UK regulatory engagement earlier into development. What ILAP involves and what it means for regulatory affairs teams.
Packaging reformulation, PFAS scrutiny, and traceability rules are pulling food and beverage companies into food contact substance regulatory work. What the hiring looks like.
A practical guide for PhDs and postdocs considering regulatory affairs: what transfers from academic research, what doesn't, and how to actually get hired.
Clinical research associates already know protocols, sites, and GCP inside out. Here is how that experience maps onto regulatory affairs, and what to build before you make the move.
FDORA's Diversity Action Plan requirement adds a new, enforceable document to clinical trial submissions. Here is what it asks for and what it means for day-to-day regulatory work.
Why companies developing opioids, stimulants, and other scheduled drugs increasingly want regulatory affairs professionals fluent in DEA registration, quotas, and diversion control.
Regulatory affairs is often sold as a desk job, but many roles carry real travel. Here is where it actually comes from and how to manage it sustainably.
Japan's Sakigake designation and its distinct regenerative medicine pathway are changing how companies staff regulatory affairs for the Japanese market.
Human cell and tissue products (HCT/Ps) run on a different regulatory track than cell and gene therapy. Here is what the work looks like and why hiring demand is growing.
The library · 201 articles · 5 categories
Every article lives on one shelf. Pick the one that fits the move you are making; each opens newest first.
Job search, interviews, offers and the moves that shape a regulatory or quality career.
Latest
What each regulatory and quality role actually does, from associate to head of function.
Latest
Where regulatory and quality hiring is growing, by product area, modality and business model.
Latest
New rules, reforms and guidances, and what they change for regulatory and quality work.
Latest
Conferences, webinars and the places the field actually gathers.
Latest
Across every category
Follow one thread through the whole library, whichever category it is filed under.